Literature DB >> 1111084

The epidemiology of enteroviruses.

N R Grist, E J Bell, D Reid.   

Abstract

International and local Scottish data illustrate the epidemiology of enteroviruses in recent years. Polioviruses still predominate as causes of serious paralytic disease, except where controlled by vaccination and require continuing surveillance. Aseptic meningitis is the commonest reported illness due to enterovirus infection, but notable clinical manifestations of certain types (particularly coxsackie group A) involve the skin and mucous membranes and the respiratory tract. Gastrointestinal disturbance has been reported in some echovirus infections, and cardiac disease is particularly associated with group B coxsackie virus infections. Although most enterovirus infections are silent or trivial in severity, the trend towards periodic epidemicity of different enteroviruses involving older age-groups may entail the emergence of new disease problems of which heart disease may be one example.

Entities:  

Mesh:

Year:  1975        PMID: 1111084     DOI: 10.1177/003693307502000108

Source DB:  PubMed          Journal:  Scott Med J        ISSN: 0036-9330            Impact factor:   0.729


  4 in total

1.  Antibodies to Coxsackie B viruses in congestive cardiomyopathy.

Authors:  G Cambridge; C G MacArthur; A P Waterson; J F Goodwin; C M Oakley
Journal:  Br Heart J       Date:  1979-06

2.  Reaction pattern of immunoglobulin M and G antibodies to echovirus 11 structural proteins.

Authors:  F Reigel; F Burkhardt; U Schilt
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

3.  Evaluation of the diagnostic work-up in children with myocarditis and idiopathic dilated cardiomyopathy.

Authors:  S L den Boer; R P J Meijer; G G van Iperen; A D J Ten Harkel; G J du Marchie Sarvaas; B Straver; L A J Rammeloo; R B Tanke; J J A van Kampen; M Dalinghaus
Journal:  Pediatr Cardiol       Date:  2014-09-07       Impact factor: 1.655

4.  Chapter 4 Picornavirus infections.

Authors: 
Journal:  Perspect Med Virol       Date:  2008-05-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.